GPR171 modulators (Omeros)

N/A

Report date: 2025/03/20 15:33:58
NME

Base Information

Drug NameGPR171 modulators (Omeros)
Drug Alias Namehematopoietic stem cell differentiation regulators (Omeros)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsFeeding and Eating DisordersImmune System DiseasesHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesOmeros Corp
Inactive CompaniesN/A
Active IndicationsFeeding and Eating Disorders
Inactive IndicationsImmune System DiseasesHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A